SQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study

[In The News]

Company Intends to Use Patient Data for Emergency Use Authorization (EUA) Submission to U.S. FDA TORONTO, Jan. 25, 2021 /PRNewswire/ - SQI Diagnostics Inc.(the "Company" or "SQI") ( (TSXV: SQD); (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes...

View the full article